Cargando…
Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia Model
BACKGROUND: Peripheral arterial disease (PAD) is a common disease accounting for about 12% of the adult population, and causes significant morbidity and mortality. Therapeutic angiogenesis using angiogenic factors has been considered to be a potential treatment option for PAD patients. In this study...
Autores principales: | Lu, Qiulun, Yao, Yihong, Yao, Yufeng, Liu, Shizhi, Huang, Yuan, Lu, Shan, Bai, Ying, Zhou, Bisheng, Xu, Yan, Li, Lei, Wang, Nan, Wang, Li, Zhang, Jie, Cheng, Xiang, Qin, Gangjian, Ma, Wei, Xu, Chengqi, Tu, Xin, Wang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479102/ https://www.ncbi.nlm.nih.gov/pubmed/23110058 http://dx.doi.org/10.1371/journal.pone.0046998 |
Ejemplares similares
-
Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease
por: Lu, Qiulun, et al.
Publicado: (2016) -
Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
por: He, Zuhan, et al.
Publicado: (2023) -
Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury
por: Yao, Yufeng, et al.
Publicado: (2017) -
Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells
por: Yu, Yubing, et al.
Publicado: (2022) -
High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma
por: Tu, Jianfei, et al.
Publicado: (2017)